Our study12 has demonstrated that tumor cells activate the HIF1A/FOSL2 (AP-1 transcription factor subunit) regulatory axis under hypoxic conditions, thereby switching tumor states and remodeling the immunosuppressive microenvironment to support tumor development. This evidence concerns the gene FOSL2 and neoplasm.